# Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion

> **NCT02920567** · NA · UNKNOWN · sponsor: **Saint Vincent's Hospital, Korea** · enrollment: 282 (estimated)

## Conditions studied

- Periampullary Tumors

## Interventions

- **DRUG:** Octreotide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02920567
- **Lead sponsor:** Saint Vincent's Hospital, Korea
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2018-06
- **Final completion:** 2018-07
- **Target enrollment:** 282 (ESTIMATED)
- **Last updated:** 2016-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02920567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02920567, "Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02920567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*